Funding Research in Africa

The ongoing Ebola epidemic in West Africa is drawing more money to study the virus, but what about funding for African science in general?

Written byPaula Park
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

FLICKR, NICOLAS RAYMONDThe Ebola outbreak in Sierra Leone, Guinea, and Liberia has laid bare the dearth of basic research funding for scientists in many African countries, which cannot afford the high-cost of building laboratories and purchasing equipment needed to study such diseases.

Since 2010, the National Institutes of Health (NIH) has provided $300 million in grants to researchers in just 17 of 54 African countries, for example, with around $200 million going to South Africa alone, according to the NIH RePort funding database.

Some donors and scientists predict the heightened awareness may result in expanded funding on not just Ebola, but also diverse neglected diseases in Africa. “Ebola has brought in very sharp relief the extent of our ignorance in Africa and the Western world” about emerging infectious diseases, said Steve Kayizzi-Mugerwa, director of development research at the African Development Bank, which collects contributions from African governments and donors to fund development across the continent. “It’s a very serious epidemic but everything has a silver lining,” he ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies